RHINARIS RELIEF 5 MG
CETIRIZINE HYDROCHLORIDE : 5 MG · DIN 02318873 · PENDOPHARM DIVISION OF PHARMASCIENCE INC
Health Canada status: APPROVED
What is RHINARIS RELIEF?
RHINARIS RELIEF 5 MG contains CETIRIZINE HYDROCHLORIDE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02318873, held by PENDOPHARM DIVISION OF PHARMASCIENCE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 10-Nov-2008. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02318873 |
|---|---|
| Brand name | RHINARIS RELIEF |
| Generic / active ingredient | CETIRIZINE HYDROCHLORIDE : 5 MG |
| Manufacturer | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Strength | 5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R06AE07 CETIRIZINE |
| AHFS class | 04:08.00 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 10-Nov-2008 |
What can be used instead?
Other Canadian products sharing ATC code R06AE07 CETIRIZINE. 27 of 65 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALLERGY RELIEF | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02240266 |
| ALLERGY RELIEF LIQUID GELS | 10 MG | CAPSULE | JUNO OTC INC | MARKETED | DIN 02528738 |
| APO-CETIRIZINE | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02231603 |
| APO-CETIRIZINE | 20 MG | TABLET | APOTEX INC | MARKETED | DIN 02453363 |
| BIO-CETIRIZINE | 20 MG | TABLET | BIOMED PHARMA | MARKETED | DIN 02510030 |
| CETIRIZINE | 20 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02534126 |
| CETIRIZINE | 20 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02515695 |
| EXTRA STRENGTH ALLERGY RELIEF | 10 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02540495 |
| EXTRA STRENGTH ALLERGY RELIEF | 10 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02315955 |
| JAMP-CETIRIZINE | 10 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02451778 |
Who else supplies CETIRIZINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CETIRIZINE appears in 177 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.